Wellnex Life Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Wellnex Life şirketinin toplam hissedar öz sermayesi A$6.1M ve toplam borcu A$10.6M olup, bu da borç-öz sermaye oranını 175.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$30.9M ve A$24.9M dir.

Anahtar bilgiler

175.2%

Borç/özkaynak oranı

AU$10.62m

Borç

Faiz karşılama oranı	n/a
Nakit	AU$956.00k
Eşitlik	AU$6.06m
Toplam yükümlülükler	AU$24.86m
Toplam varlıklar	AU$30.92m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: WNX 'nin kısa vadeli varlıkları ( A$9.9M ) kısa vadeli yükümlülüklerini ( A$24.8M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: WNX şirketinin kısa vadeli varlıkları ( A$9.9M ) uzun vadeli yükümlülüklerini ( A$86.0K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: WNX 'nin net borç/öz sermaye oranı ( 159.4% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: WNX şirketinin borç/öz sermaye oranı son 5 yılda 4% seviyesinden 175.2% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: WNX son raporlanan serbest nakit akışına göre 2 ay boyunca yeterli nakit pistine sahiptir, ancak o zamandan beri ek sermaye artırmıştır.

Tahmini Nakit Akışı: WNX serbest nakit akışı tahminlerine göre 1 ay boyunca yeterli nakit akışına sahip olması öngörülüyor, ancak o zamandan beri ek sermaye artırdı.

Wellnex Life Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Wellnex Life Limited, Annual General Meeting, Nov 29, 2024

Investors Give Wellnex Life Limited (ASX:WNX) Shares A 35% Hiding

New major risk - Market cap size

Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.034 loss in FY 2023)

MD & Executive Director recently bought AU$250k worth of stock

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.034 loss in FY 2023)

Wellnex Life Limited Provides Earnings Guidance for the Year 2025

Wellnex Life Limited Announces Launch of Medicinal Cannabis Brand Wellness Life

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 2.065876 million.

Wellnex Life Limited's (ASX:WNX) 29% Jump Shows Its Popularity With Investors

New major risk - Share price stability

Wellnex Life Limited (ASX:WNX) Might Not Be As Mispriced As It Looks

Wellnex Life Limited has filed a Follow-on Equity Offering in the amount of AUD 1.000028 million.

Less than half of directors are independent

Wellnex Life Limited Announces Board Appointments

It's A Story Of Risk Vs Reward With Wellnex Life Limited (ASX:WNX)

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 1.507508 million.

Wellnex Life Limited (ASX:WNX) completed the acquisition of business and assets of Pain Away from 365 Health Australia Pty Limited, Ziptime Pty Limited, One Zero Pty Limited, Twisobell Health Pty Limited.

New major risk - Shareholder dilution

Wellnex Life Limited, Annual General Meeting, Dec 14, 2023

Wellnex Life Limited has filed a Follow-on Equity Offering in the amount of AUD 13.643905 million.

Wellnex Life Limited has filed a Follow-on Equity Offering.

Wellnex Life Limited Announces Board Changes

Wellnex Life Limited Provides Revenue Guidance for the Fiscal Year 2024

Wellnex Life Limited has completed a Follow-on Equity Offering in the amount of AUD 2.2 million.

First half 2023 earnings released: AU$0.013 loss per share (vs AU$0.007 loss in 1H 2022)

Wellnex Life Limited Announces Pharmacy Own Products Update

Wellnex Life Limited Provides Revenue Guidance for the Second Half of 2023; Reaffirms Revenue Guidance for the Year 2023

Wellnex Life Limited (ASX:WNX) completed the acquisition of Mr Bright smile.

Wellnex Life Limited Reconfirms Revenue Guidance for the Fiscal Year 2023

Wellnex Announces Launch of E-Commerce Platform and Brand

Wellnex Life Limited, Annual General Meeting, Nov 29, 2022

Wellnex Life Limited Launches Two New Brands

Full year 2022 earnings released: AU$0.025 loss per share (vs AU$0.10 loss in FY 2021)

Wellnex Life Limited (ASX:WNX) entered into a binding Asset Sale Agreement to acquire Agreement to acquire for AUD 1.5 million.

Wellnex Life Limited Reaffirms Revenue Guidance for the Fiscal Year 2023

Wellnex Life Limited Reaffirms Revenue Guidance for the Fiscal Year 2023

Full year 2022 earnings released: AU$0.025 loss per share (vs AU$0.10 loss in FY 2021)

Insider recently bought AU$511k worth of stock

Wellnex Life Limited Provides Earnings Guidance for the Fiscal Year 2023

Wellnex Life Limited announced that it has received AUD 6.2 million in funding

Full year 2021 earnings released: AU$0.10 loss per share (vs AU$0.23 loss in FY 2020)

Full year 2021 earnings released: AU$0.10 loss per share (vs AU$0.23 loss in FY 2020)

Wellnex Life Limited and epharmacy Group Pty Ltd Announce the Launch of New Products Under Wagner Liquigesic Brand

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin